Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Leslie D. Funtleyder Insider Profile
4 Followers
Leslie D. Funtleyder, Interim CEO and CFO, Director at Applied Therapeutics, holds 404.96K shares in Applied Therapeutics (Ticker: APLT), holds ― shares in Reviva Pharmaceuticals Holdings (Ticker: RVPH). Most recently, Leslie D. Funtleyder Sold ― shares of Applied Therapeutics on Feb 07, 2025 for an estimated value of 14.00K.
Leslie D. Funtleyder Applied Therapeutics (APLT)Interim CEO and CFO, Director
Applied Therapeutics (APLT)
Interim CEO and CFO, Director
Ranked #1,744 out of 100,516 Corporate Insiders
Profitable Transactions
9 out of 10 Profitable Transactions
Average Return
+55.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Leslie D. Funtleyder holds in companies
Most Profitable Insider Trade
The most profitable trade made by Leslie D. Funtleyder
Leslie D. Funtleyder's Trading History
Applied Therapeutics
Feb 07, 2025
Interim CEO and CFO, Director
Informative Sell
14.00K
$228.80K
Reviva Pharmaceuticals Holdings
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Leslie D. Funtleyder's performance on stock
You May Also Like
Leslie D. Funtleyder insider profile FAQ
What is the percentage of profitable transactions made by Leslie D. Funtleyder?
The percentage of profitable transactions made by Leslie D. Funtleyder is 90%.
What is the average return per transaction made by Leslie D. Funtleyder?
The average return per transaction made by Leslie D. Funtleyder is 55.70%.
What stocks does Leslie D. Funtleyder hold?
Leslie D. Funtleyder holds: APLT, RVPH stocks.
What was Leslie D. Funtleyder’s latest transaction?
Leslie D. Funtleyder latest transaction was an Informative Sell of $14.00K.
What was Leslie D. Funtleyder's most profitable transaction?
Leslie D. Funtleyder’s most profitable transaction was an Informative Sell of APLT stock on March 18, 2024. The return on the trade was 89.70%.
What is Leslie D. Funtleyder's role in Applied Therapeutics?
Leslie D. Funtleyder's role in Applied Therapeutics is Interim CEO and CFO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.